673
Participants
Start Date
July 31, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Methotrexate
7.5-20mg po weekly
tocilizumab [RoActemra/Actemra]
8mg/kg iv every 4 weeks
Lima
Lima
Ljubljana
Diepkloof
Maribor
Radiokop
Sydney
Copenhagen
Lillehammer
Hvidovre
Hillerød
Cape Town
Woolloongabba
Woodville
Adelaide
Shenton Park
Hobart
Pinelands
Cape Town
Levanger
Belgrade
Albany
Syracuse
Córdoba
Mexico City
Santiago de Compostela
Genova
Duncansville
Niška Banja
Guadalajara
Willow Grove
Philadelphia
Wyomissing
Milan
Greenbelt
Chesapeake
Lugo
Pavia
Fayetteville
Hickory Grove
Alcorcón
Columbia
Charleston
Greenville
Brest
Haifa
Port Orange
Jupiter
Tampa
Tampa
Haifa
Palm Habor
Palm Harbor
Panevezys
Montgomery
Salamanca
Nashville
Hixson
San Cristóbal de La Laguna
Tupelo
Flowood
Reggio Emilia
Bowling Green
Mayfield
Kfar Saba
Guadalajara
Guadalajara
Canton
Guadalajara
Valencia
Indianapolis
Lansing
Kalamazoo
Grand Rapids
Kaunas
Des Moines
Cedar Rapids
Ramat Gan
Siena
Eagan
Saint Cloud
Morton Grove
Springfield
St Louis
St Louis
Lyon
Rishon LeZiyyon
Slidell
Baton Rouge
Little Rock
Oklahoma City
Oklahoma City
Tulsa
Tulsa
Mesquite
Paris
Rouen
Šiauliai
Ashkelon
Austin
Amarillo
Idaho Falls
Meridian
Phoenix
Mesa
Paradise Valley
Los Angeles
Long Beach
Palm Springs
Klaipėda
Huntington Beach
Santa Maria
San Leandro
Sacramento
Mountlake Terrace
Olympia
Yakima
Spokane
Hefei Anhui
Jinan
Guangzhou
Beersheba
Pittsfield
Dover
Nashua
Haddon Heights
Barcelona
New Brunswick
Buenos Aires
Buenos Aires
Rosario
San Juan Bautista
Victoria
Winnipeg
Winnipeg
St. John's
Burlington
Hamilton
Kitchener
Mississauga
Ottawa
Vilnius
Mexico City
Mexico City
Almada
Lisbon
Lisbon
Hoffmann-La Roche
INDUSTRY